Axsome Therapeutics, Inc. (AXSM)
NASDAQ: AXSM · IEX Real-Time Price · USD
84.55
+2.05 (2.48%)
At close: Jul 11, 2024, 4:00 PM
84.85
+0.30 (0.35%)
After-hours: Jul 11, 2024, 7:47 PM EDT

Axsome Therapeutics Stock Forecast

Stock Price Forecast

The 11 analysts with 12-month price forecasts for Axsome Therapeutics stock have an average target of 123.55, with a low estimate of 81 and a high estimate of 190. The average target predicts an increase of 46.13% from the current stock price of 84.55.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $81 $123.55 $115 $190
Change -4.20% +46.13% +36.01% +124.72%
* Price targets were last updated on Jun 6, 2024.

Analyst Ratings

The average analyst rating for AXSM stock from 12 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating Feb '24Mar '24Apr '24May '24Jun '24Jul '24
Strong Buy 566666
Buy 345555
Hold 221111
Sell 000000
Strong Sell 000000
Total 101212121212

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Mizuho
Mizuho
Strong Buy
Reiterates
n/a
Strong Buy Reiterates n/a n/a Jun 12, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$190
Strong Buy Reiterates $190 +124.72% Jun 6, 2024
RBC Capital
RBC Capital
Buy
Maintains
$127$130
Buy Maintains $127$130 +53.76% Jun 5, 2024
Mizuho
Mizuho
Strong Buy
Maintains
$109$106
Strong Buy Maintains $109$106 +25.37% May 8, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$190
Strong Buy Reiterates $190 +124.72% May 7, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
383.76M
from 270.60M
Increased by 41.82%
Revenue Next Year
684.92M
from 383.76M
Increased by 78.48%
EPS This Year
-4.93
from -5.27
EPS Next Year
-0.48
from -4.93
Year 2019202020212022202320242025202620272028
Revenue
---50.04M270.60M383.76M684.92M1.18B1.62B2.06B
Revenue Growth
----440.80%41.82%78.48%72.57%36.63%27.62%
EPS
-2.01-2.77-3.47-4.60-5.27-4.93-0.486.388.5812.97
EPS Growth
--------34.36%51.19%
Forward PE
-------13.249.866.52
No. Analysts -----18181466
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 464.9M 919.1M 1.8B 2.3B 2.8B
Avg 383.8M 684.9M 1.2B 1.6B 2.1B
Low 340.2M 458.4M 856.8M 1.2B 1.6B

Revenue Growth

Revenue Growth 20242025202620272028
High
71.8%
139.5%
155.8%
95.6%
73.7%
Avg
41.8%
78.5%
72.6%
36.6%
27.6%
Low
25.7%
19.4%
25.1%
5.6%
-1.4%

EPS Forecast

EPS 20242025202620272028
High -3.80 3.57 14.49 12.79 18.09
Avg -4.93 -0.48 6.38 8.58 12.97
Low -6.10 -3.90 -0.91 2.68 8.57

EPS Growth

EPS Growth 20242025202620272028
High - - -
100.3%
110.9%
Avg - - -
34.4%
51.2%
Low - - -
-58.1%
-0.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.